Paper · 18445007
Identification of two subpopulations of purified human blood B cells, CD27- CD23+ and CD27high CD80+, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6.
Cognasse F and 6 others. Immunology, 2008. Cited by 35 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Identification of two subpopulations of purified human blood B cells, CD27- CD23+ and CD27high CD80+, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6. Papers, record 18445007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18445007
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification of two subpopulations of purified human blood B cells, CD27- CD23+ and CD27high CD80+, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocyte Subsets | Major topic |
| Interleukin-6 | Major topic |
| Toll-Like Receptor 9 | Major topic |
| B7-1 Antigen | |
| Cell Membrane | |
| Cells, Cultured | |
| CpG Islands | |
| Humans | |
| Immunologic Memory | |
| Lymphocyte Activation | |
| Receptors, IgE | |
| Tumor Necrosis Factor Receptor Superfamily, Member 7 |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17,621,369 | TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function. | Eur J Immunol | 2007 | https://conductscience.org/library/papers/17621369 | PubMed |
| 2 | 17,000,899 | Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19. | J Leukoc Biol | 2006 | https://conductscience.org/library/papers/17000899 | PubMed |
| 3 | 15,698,512 | Differential downstream effects of CD40 ligation mediated by membrane or soluble CD40L and agonistic Ab: a study on purified human B cells. | Int J Immunopathol Pharmacol | 2005 | https://conductscience.org/library/papers/15698512 | PubMed |
| 4 | 18,178,818 | CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. | J Immunol | 2008 | https://conductscience.org/library/papers/18178818 | PubMed |
| 5 | 14,707,068 | IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. | J Immunol | 2004 | https://conductscience.org/library/papers/14707068 | PubMed |
| 6 | 16,780,564 | A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation. | Immunology | 2006 | https://conductscience.org/library/papers/16780564 | PubMed |
| 7 | 17,032,927 | CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells. | Blood | 2007 | https://conductscience.org/library/papers/17032927 | PubMed |
| 8 | 12,481,138 | Maintenance of serological memory by polyclonal activation of human memory B cells. | Science | 2002 | https://conductscience.org/library/papers/12481138 | PubMed |
| 9 | 11,970,999 | Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. | J Immunol | 2002 | https://conductscience.org/library/papers/11970999 | PubMed |
| 10 | 16,188,245 | Expression of toll-like receptors on B lymphocytes. | Cell Immunol | 2005 | https://conductscience.org/library/papers/16188245 | PubMed |
1 to 10 of 48
See all 48 referencesCited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,384,292 | Response to Commentary: Memory B Cells in Major Depressive Disorder: Toward Mechanistic and Clinical Refinement. | Curr Med Sci | 2026 | https://conductscience.org/library/papers/42384292 | PubMed |
| 41,528,645 | Bidirectional Mendelian Randomization and Colocalization Study of Memory B Cells and Major Depressive Disorder. | Curr Med Sci | 2026 | https://conductscience.org/library/papers/41528645 | PubMed |
| 39,494,905 | Lipid nanoparticles as adjuvant of norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9- and type I IFN-dependent pathway. | J Virol | 2024 | https://conductscience.org/library/papers/39494905 | PubMed |
| 34,168,647 | Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis. | Front Immunol | 2021 | https://conductscience.org/library/papers/34168647 | PubMed |
| 33,950,279 | CpG ODN as an adjuvant arouses the vigor of B cells by relieving the negative regulation of surface TLR9 to enhance the antibody response to vaccine. | Appl Microbiol Biotechnol | 2021 | https://conductscience.org/library/papers/33950279 | PubMed |
| 27,812,176 | Lipopolysaccharides-Induced Suppression of Innate-Like B Cell Apoptosis Is Enhanced by CpG Oligodeoxynucleotide and Requires Toll-Like Receptors 2 and 4. | PLoS One | 2016 | https://conductscience.org/library/papers/27812176 | PubMed |
| 25,790,192 | Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome. | PLoS One | 2015 | https://conductscience.org/library/papers/25790192 | PubMed |
| 25,196,729 | The CD27+ memory B cells display changes in the gene expression pattern in elderly individuals. | Immunology | 2014 | https://conductscience.org/library/papers/25196729 | PubMed |
| 23,194,300 | Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond. | BMC Immunol | 2012 | https://conductscience.org/library/papers/23194300 | PubMed |
| 22,547,654 | B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. | J Exp Med | 2012 | https://conductscience.org/library/papers/22547654 | PubMed |
1 to 10 of 20
See all 20 cited byGenes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD19 | 930 | PubTator's text mining | https://conductscience.org/library/genes/930 | NCBI Gene |
| CD27 | 939 | PubTator's text mining | https://conductscience.org/library/genes/939 | NCBI Gene |
| CD80 | 941 | PubTator's text mining | https://conductscience.org/library/genes/941 | NCBI Gene |
| FCER2 | 2,208 | PubTator's text mining | https://conductscience.org/library/genes/2208 | NCBI Gene |
| IL6 | 3,569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| TLR9 | 54,106 | PubTator's text mining | https://conductscience.org/library/genes/54106 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18445007
GET https://conductscience.org/api/papers/v1/18445007/references?page=2